If you are having trouble viewing this email, please view it on our website

A Service Announcement from Pharmexec
 Pharmaceutical Executive
Copay offset cards have gained a great deal of popularity in the pharmaceutical industry. They are quite popular with patients and provide them an important economic benefit. Several payers do not view some copay cards favorably. This situation gives rise to three critical questions:
  1. Will copay offset cards continue to be offered in the future?
  2. Will they be modified in any way?
  3. Or will they be discontinued in the near future?
This is an important marketing issue and in order to make a sound decision in this matter a good understanding of the attitudes and experiences of all the stakeholders is necessary. To provide this information in detail Alliance Life Sciences is conducting a syndicated study on this topic.

The entire project is described in the brochure. The study is based on a sound methodology. Click the link below to view the brochure.

Prescription Copay Offset Card - A Syndicated Study

A presentation on the study can be provided. You are invited to purchase this study and gain access to this critical information. The study is currently available at a pre-publication discount price until December 20th.

We are also launching a new syndicated study on "E-prescribing of Pharmaceuticals – marketing opportunities and caveats for pharmaceutical companies based on physician experiences". If you would like to obtain more information, please send us an email at the address in the copay brochure.

Cordially,
Dilip Phadnis
Director, Syndicated Research
201 819 6097

Alliance Life Sciences
265 Davidson Avenue, Ste 310 Somerset, NJ 08873,
www.alscg.com

If you no longer wish to receive emails from Alliance Life Sciences, please Click Here

Pharmaceutical Executive is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ
This is an advertisement sent on behalf of this advertiser.